Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
US-9163022-B2 · Oct 20, 2015 · US
High Point Pharmaceuticals Llc was listed as an assignee on 1 patent publication in 2015.
| Metric | Value |
|---|---|
| Company | High Point Pharmaceuticals Llc |
| Year | 2015 |
| Patents | 1 |
Representative publications for High Point Pharmaceuticals Llc in 2015.
Most common classification codes for High Point Pharmaceuticals Llc in 2015.
| CPC | Patents |
|---|---|
| A61K31/519 | 1 |
| A61P1/00 | 1 |
| A61P1/02 | 1 |
| A61P1/04 | 1 |
| A61P1/10 | 1 |
Navigate to parent entity pages.